Gupta K, Scholes D, Stamm W E
Department of Medicine, University of Washington School of Medicine, Seattle 98195, USA.
JAMA. 1999 Feb 24;281(8):736-8. doi: 10.1001/jama.281.8.736.
Guidelines for the management of acute uncomplicated cystitis in women that recommend empirical therapy in properly selected patients rely on the predictability of the agents causing cystitis and knowledge of their antimicrobial susceptibility patterns.
To assess the prevalence of and trends in antimicrobial resistance among uropathogens causing well-defined episodes of acute uncomplicated cystitis in a large population of women.
Cross-sectional survey of antimicrobial susceptibilities of urine isolates collected during a 5-year period (January, May, and September 1992-1996).
Health maintenance organization.
Women aged 18 to 50 years with an outpatient diagnosis of acute cystitis.
Proportion of uropathogens demonstrating in vitro resistance to selected antimicrobials; trends in resistance over the 5-year study period.
Escherichia coli and Staphylococcus saprophyticus were the most common uropathogens, accounting for 90% of the 4342 urine isolates studied. The prevalence of resistance among E coli and all isolates combined was more than 20% for ampicillin, cephalothin, and sulfamethoxazole in each year studied. The prevalence of resistance to trimethoprim and trimethoprim-sulfamethoxazole rose from more than 9% in 1992 to more than 18% in 1996 among E coli, and from 8% to 16% among all isolates combined. There was a statistically significant increasing linear trend in the prevalence of resistance from 1992 to 1996 among E coli and all isolates combined to ampicillin (P<.002), and to cephalothin, trimethoprim, and trimethoprim-sulfamethoxazole (P<.001). In contrast, the prevalence of resistance to nitrofurantoin, gentamicin, and ciprofloxacin hydrochloride was 0% to 2% among E coli and less than 10% among all isolates combined, and did not change significantly during the 5-year period.
While the prevalence of resistance to trimethoprim-sulfamethoxazole, ampicillin, and cephalothin increased significantly among uropathogens causing acute cystitis, resistance to nitrofurantoin and ciprofloxacin remained infrequent. These in vitro susceptibility patterns should be considered along with other factors, such as efficacy, cost, and cost-effectiveness in selecting empirical therapy for acute uncomplicated cystitis in women.
针对女性急性单纯性膀胱炎的管理指南建议,在恰当选择的患者中进行经验性治疗,这依赖于引起膀胱炎的病原体的可预测性及其抗菌药物敏感性模式的知识。
评估在大量女性人群中,引起明确的急性单纯性膀胱炎发作的尿路病原体的抗菌药物耐药性的流行情况和趋势。
对1992年至1996年5年期间(1月、5月和9月)收集的尿液分离株的抗菌药物敏感性进行横断面调查。
健康维护组织。
年龄在18至50岁、门诊诊断为急性膀胱炎的女性。
对选定抗菌药物表现出体外耐药性的尿路病原体比例;5年研究期间的耐药趋势。
大肠埃希菌和腐生葡萄球菌是最常见的尿路病原体,占所研究的4342株尿液分离株的90%。在所研究的每年中,大肠埃希菌以及所有分离株对氨苄西林、头孢噻吩和磺胺甲恶唑的耐药率均超过20%。大肠埃希菌对甲氧苄啶和甲氧苄啶 - 磺胺甲恶唑的耐药率从1992年的9%以上升至1996年的18%以上,所有分离株的耐药率从8%升至16%。从1992年至1996年,大肠埃希菌以及所有分离株对氨苄西林(P<0.002)、头孢噻吩、甲氧苄啶和甲氧苄啶 - 磺胺甲恶唑的耐药率呈统计学显著的线性上升趋势(P<0.001)。相比之下,大肠埃希菌对呋喃妥因、庆大霉素和盐酸环丙沙星的耐药率为0%至2%,所有分离株的耐药率低于10%,且在5年期间无显著变化。
虽然在引起急性膀胱炎的尿路病原体中,对甲氧苄啶 - 磺胺甲恶唑、氨苄西林和头孢噻吩的耐药率显著上升,但对呋喃妥因和环丙沙星的耐药情况仍然较少。在为女性急性单纯性膀胱炎选择经验性治疗时,应结合其他因素,如疗效、成本和成本效益,考虑这些体外药敏模式。